Maite Bourlon/ascopubs.org
Mar 2, 2025, 14:36
Maite Bourlon: How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab
Maite Bourlon, Associate Professor and Head of the Urologic Oncology Clinic at the National Institute of Medical Sciences and Nutrition Salvador Zubirán, shared a post on X:
“How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab?
- Lack of evidence and need trials
- Look at proposed algorithm
- Ongoing trials mUC after EV and ICIs
- Table of efficacy outcomes of platinum, erdafitinib (FGFR3) and trastu deruxtecan.”
Authors: Maria Bourlon, Paola Valdez, Thomas Powles, Thomas Flaig.
More posts featuring Maite Bourlon.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 8, 2025, 17:31
May 8, 2025, 17:30
May 8, 2025, 15:53
May 8, 2025, 15:14
May 8, 2025, 15:13